Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.291, 2000-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Methotrexate: PROMPT treatment prevents progression to RA
Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. :
Access to resources
Recommend
Tocilizumab ± methotrexate beneficial for RA
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
Treatment Options for Multidrug-Resistant Acinetobacter Species
By Gilad Jacob
Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. :
Infliximab may be cost effective in severe, treatment-resistant RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
Infliximab may be cost effective in severe, treatment-resistant RA
Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. :